(NU/1433- 9) PulmoBiomed: The Provision of Business Consultancy to Assist Commercialisation of University Research.

Universities are rising to the challenge of commercialisation inventions, research, innovations, discovery and intellectual property. This is done through a variety of methods and funding sources which are made available to Universities. One of which is the Northern Accelerator brand.

PulmoBiomed Technology

Breath analysis opens up a new non-invasive source of diagnostic data. Solving the challenges of creating a diagnostic platform based on breath will generate a raft of patient-centred solutions, products and commercial opportunities.

The initial brief of the executive will be to:

1. Produce a viable business plan;
2. Obtain university approval for the venture;

(3a) Act for the company in the spin-out legal process and address all company formation matters;

(3b) Obtain founder academics' and Northumbria University (including the Director of Research and Innovation) approval for appointment as CEO.

(3c) Provide to the appropriate university all matters necessary for ERDF / Research England reporting requirements;

4. Secure (venture capital and / or other) funding in accordance with the business plan.